Abstracts - faqs.org

Abstracts

News, opinion and commentary

Search abstracts:
Abstracts » News, opinion and commentary

Synsorb braces for key FDA meeting

Article Abstract:

Synsorb Inc's proposal to acquire cancer researcher Oncolytics Biotech Inc is the latest in its series of moves to expand its pipeline with potential pharmaceutical product. The company is currently renegotiating its planned acquisition of a one-third state in GeneSense Technology Inc of Winnipeg, Manitoba, for C$9.5 million in stock. Synsorb also signed a collaborative deal with antibiotic researcher Ocean Pharmaceuticals Inc of White Rock, British Columbia.

Author: Zehr, Leonard
Publisher: Bell Globemedia Interactive
Publication Name: Globe & Mail (Toronto, Canada)
Subject: News, opinion and commentary
ISSN: 0319-0714
Year: 1999
Oncolytics Biotech Inc.

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


BioChem acquires stake in hospital-bug vaccine company

Article Abstract:

Laval, Que.-based BioChem Pharma Inc. has acquired a minority stake in Edmonton-based Cytovax Biotechnologies Inc. for about $11 million. BioChem, which wants to increase its development of vaccines, also paid $13.5 million for vaccine development programs.

Author: Zehr, Leonard
Publisher: Bell Globemedia Interactive
Publication Name: Globe & Mail (Toronto, Canada)
Subject: News, opinion and commentary
ISSN: 0319-0714
Year: 2000
Mergers, acquisitions and divestments, Cytovax Biotechnologies Inc.

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Despite slumping profit, BioChem tops expectations

Article Abstract:

BioChem Pharma Inc. posted a drop in profits to C$45 million for the 2000 fourth-quarter. The company, which still posted higher-than-expected results, posted C$51.1 million in profits in the 1999 fourth-quarter.

Author: Zehr, Leonard
Publisher: Bell Globemedia Interactive
Publication Name: Globe & Mail (Toronto, Canada)
Subject: News, opinion and commentary
ISSN: 0319-0714
Year: 2001
Sales, profits & dividends, Finance

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Canada, Biological products, Biological products industry, Shire BioChem Inc., BCHE
Similar abstracts:
  • Abstracts: Centra Gas found 'imprudent' in trading. Assante bulks up with acquisitions. The little firm that makes Churchill work
  • Abstracts: DWL secures financing deal. Venture capitalists profit in tech sector. Classwave Wireless wins venture capital deal
  • Abstracts: Delphi, Palm unveil Internet device for cars. Pivotal warns first-quarter profit below expectations. IBM launches fastest computer
  • Abstracts: TransCanada forges prized gas link to California. Petrocan selling Nfld. gas stations
  • Abstracts: Canadians outsurf U.S. cousins. Coffee king sings praises of e-business consultant
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.